文献速递胸部肿瘤放疗放疗物理与技术

CT通气图像引导螺旋断层放疗保护局部晚期肺癌功能性肺:剂量-功能指标分析及对肺毒性的影响

CT ventilation image-guided helical Tomotherapy at sparing functional lungs for locally advanced lung cancer: analysis of dose-function metrics and the impact on pulmonary toxicity.
PubMed 文献 · Radiat Oncol · 2023-01-09

本研究对17例局部晚期肺癌患者基于4DCT生成CT通气图,为每例设计1个解剖计划和5个功能计划(分别保护通气百分位前10%、20%、30%、40%、50%高功能区),用基于剂量-功能的NTCP模型估算放射性肺炎风险。功能计划可降低高功能区剂量(回避范围可达前50%),但以增加其他危及器官剂量为代价;通气空间分布与肿瘤体积是筛选获益患者的关键因素。

要点

  • 基于4DCT的通气图可指导螺旋断层放疗选择性保护高功能肺区,回避范围可达通气百分位前50%。
  • 8例获益组中,从保护前30%功能计划起,fV5、fV10、fV20和fMLD均显著低于解剖计划(P<0.05)。
  • 功能计划不牺牲PTV覆盖(P>0.05),但以增加其他危及器官剂量为代价。

核心结论

  • 通气图像引导的螺旋断层放疗计划可降低高功能肺区所受剂量,回避范围可达通气面积前50%。
  • 通气的空间分布和肿瘤大小是更好筛选可从功能计划获益患者的关键因素。

研究设计与样本

  • 对17例局部晚期肺癌患者行治疗前4DCT扫描,基于呼气末和吸气末两套CT图像经可变形配准和Jacobian算法生成通气图并归一化为百分位图像。
  • 每例设计6个计划:1个不含通气图的解剖计划,以及5个分别保护通气百分位前10%、20%、30%、40%、50%高功能肺区的功能计划。
  • 记录PTV和其他危及器官的剂量学与评估指标,重点关注全肺和功能肺所受剂量,并用已建立的基于剂量-功能的正常组织并发症概率(NTCP)模型估算各方案的放射性肺炎(RP)风险。

主要发现

  • 根据功能计划的RP风险是否低于解剖计划,将患者分为获益组(8例)和非获益组(9例)。
  • 高通气区与PTV之间的距离以及肿瘤体积在两组间差异有统计学意义(P<0.05)。
  • 获益组中,从保护前30%功能计划起,fV5、fV10、fV20和fMLD的均值显著低于解剖计划(P<0.05)。
  • 随着功能计划回避区域扩大,PTV剂量覆盖未牺牲(P>0.05),但以增加危及器官所受剂量为代价。

关键数值与推荐

  • 功能肺区定义为通气百分位范围前10%、20%、30%、40%、50%的高功能区。
  • 获益组从保护前30%功能计划起,fV5、fV10、fV20和fMLD均显著低于解剖计划(P<0.05)。
  • 高通气区与PTV距离及肿瘤体积在获益组与非获益组间差异有统计学意义(P<0.05)。
  • PTV剂量覆盖在功能计划与解剖计划间差异无统计学意义(P>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: CT ventilation image (CTVI)-guided radiotherapy that selectively avoids irradiating highly-functional lung regions has potential to reduce pulmonary toxicity. Considering Helical TomoTherapy (HT) has higher modulation capabilities, we investigated the capability and characteristic of HT at sparing functional lungs for locally advanced lung cancer. METHODS AND MATERIALS: Pretreatment 4DCT scans were carried out for 17 patients. Local lung volume expansion (or contraction) during inspiration is related to the volume change at a given lung voxel and is used as a surrogate for ventilation. The ventilation maps were generated from two sets of CT images (peak-exhale and peak-inhale) by deformable registration and a Jacobian-based algorithm. Each ventilation map was normalized to percentile images. Six plans were designed for each patient: one anatomical plan without ventilation map and five functional plans incorporating ventilation map which designed to spare varying degrees of high-functional lungs that were defined as the top 10%, 20%, 30%, 40%, and 50% of the percentile ventilation ranges, respectively. The dosimetric and evaluation factors were recorded regarding planning target volume (PTV) and other organs at risk (OARs), with particular attention to the dose delivered to total lung and functional lungs. An established dose-function-based normal tissue complication probability (NTCP) model was used to estimate risk of radiation pneumonitis (RP) for each scenario. RESULTS: Patients were divided into a benefit group (8 patients) and a non-benefit group (9 patients) based on whether the RP-risk of functional plan was lower than that of anatomical plan. The distance between high-ventilated region and PTV, as well as tumor volume had significant differences between the two groups (P < 0.05). For patients in the benefit group, the mean value of fV5, fV10, fV20, and fMLD (functional V5, V10, V20, and mean lung dose, respectively) were significantly lower starting from top 30% functional plan than in anatomical plan (P < 0.05). With expand of avoidance region in functional plans, the dose coverage of PTV is not sacrificed (P > 0.05) but at the cost of increased dose received by OARs. CONCLUSION: Ventilation image-guided HT plans can reduce the dose received by highly-functional lung regions with a range up to top 50% ventilated area. The spatial distribution of ventilation and tumor size were critical factors to better select patients who could benefit from the functional plan.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li S, Liu J, Gao S, et al. CT ventilation image-guided helical Tomotherapy at sparing functional lungs for locally advanced lung cancer: analysis of dose-function metrics and the impact on pulmonary toxicity. Radiat Oncol. 2023. PMID: 36624537. doi:10.1186/s13014-022-02189-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。